These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9322869)

  • 1. Retroviral vector-mediated transfer of an antisense cyclin G1 construct inhibits osteosarcoma tumor growth in nude mice.
    Chen DS; Zhu NL; Hung G; Skotzko MJ; Hinton DR; Tolo V; Hall FL; Anderson WF; Gordon EM
    Hum Gene Ther; 1997 Sep; 8(14):1667-74. PubMed ID: 9322869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral vector-mediated gene transfer of antisense cyclin G1 (CYCG1) inhibits proliferation of human osteogenic sarcoma cells.
    Skotzko M; Wu L; Anderson WF; Gordon EM; Hall FL
    Cancer Res; 1995 Dec; 55(23):5493-8. PubMed ID: 7585620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of rabbit keratocyte and human fetal lens epithelial cell proliferation by retrovirus-mediated transfer of antisense cyclin G1 and antisense MAT1 constructs.
    Kampmeier J; Behrens A; Wang Y; Yee A; Anderson WF; Hall FL; Gordon EM; McDonnell PJ
    Hum Gene Ther; 2000 Jan; 11(1):1-8. PubMed ID: 10646634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation.
    Zhu NL; Wu L; Liu PX; Gordon EM; Anderson WF; Starnes VA; Hall FL
    Circulation; 1997 Jul; 96(2):628-35. PubMed ID: 9244236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term inhibition of neointima formation in balloon-injured rat arteries by intraluminal instillation of a matrix-targeted retroviral vector bearing a cytocidal mutant cyclin G1 construct.
    Xu F; Prescott MF; Liu PX; Chen ZH; Liau G; Gordon EM; Hall FL
    Int J Mol Med; 2001 Jul; 8(1):19-30. PubMed ID: 11408944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of metastatic tumor growth in nude mice by portal vein infusions of matrix-targeted retroviral vectors bearing a cytocidal cyclin G1 construct.
    Gordon EM; Liu PX; Chen ZH; Liu L; Whitley MD; Gee C; Groshen S; Hinton DR; Beart RW; Hall FL
    Cancer Res; 2000 Jul; 60(13):3343-7. PubMed ID: 10910035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in mice.
    Gordon EM; Chen ZH; Liu L; Whitley M; Liu L; Wei D; Groshen S; Hinton DR; Anderson WF; Beart RW; Hall FL
    Hum Gene Ther; 2001 Jan; 12(2):193-204. PubMed ID: 11177556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bystander-mediated regression of osteosarcoma via retroviral transfer of the herpes simplex virus thymidine kinase and human interleukin-2 genes.
    Walling HW; Swarthout JT; Culver KW
    Cancer Gene Ther; 2000 Feb; 7(2):187-96. PubMed ID: 10770626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral gene therapy vectors for prevention of excimer laser-induced corneal haze.
    Behrens A; Gordon EM; Li L; Liu PX; Chen Z; Peng H; La Bree L; Anderson WF; Hall FL; McDonnell PJ
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):968-77. PubMed ID: 11923236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.
    Arber N; Doki Y; Han EK; Sgambato A; Zhou P; Kim NH; Delohery T; Klein MG; Holt PR; Weinstein IB
    Cancer Res; 1997 Apr; 57(8):1569-74. PubMed ID: 9108461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical protocol. Tumor site specific phase I evaluation of safety and efficacy of hepatic arterial infusion of a matrix-targeted retroviral vector bearing a dominant negative cyclin G1 construct as intervention for colorectal carcinoma metastatic to liver.
    Lenz HJ; Anderson WF; Hall FL; Gordon EM
    Hum Gene Ther; 2002 Aug; 13(12):1515-37. PubMed ID: 12215272
    [No Abstract]   [Full Text] [Related]  

  • 12. Technology evaluation: Rexin-G, Epeius Biotechnologies.
    Morse M
    Curr Opin Mol Ther; 2005 Apr; 7(2):164-9. PubMed ID: 15844625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II and phase II studies of targeted gene delivery in vivo: intravenous Rexin-G for chemotherapy-resistant sarcoma and osteosarcoma.
    Chawla SP; Chua VS; Fernandez L; Quon D; Saralou A; Blackwelder WC; Hall FL; Gordon EM
    Mol Ther; 2009 Sep; 17(9):1651-7. PubMed ID: 19532136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transduction of antisense cyclin D1 using two-step gene transfer inhibits the growth of rat hepatoma cells.
    Uto H; Ido A; Moriuchi A; Onaga Y; Nagata K; Onaga M; Tahara Y; Hori T; Hirono S; Hayashi K; Tsubouchi H
    Cancer Res; 2001 Jun; 61(12):4779-83. PubMed ID: 11406552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of cyclin g1 expression in human uterine leiomyoma cells induces apoptosis.
    Kwon SH; Park JC; Ramachandran S; Cha SD; Kwon KY; Park JK; Park JW; Bae I; Cho CH
    Reprod Sci; 2008 Apr; 15(4):400-10. PubMed ID: 18497347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo gene transfer between interacting human osteosarcoma cell lines is associated with acquisition of enhanced metastatic potential.
    Tome Y; Tsuchiya H; Hayashi K; Yamauchi K; Sugimoto N; Kanaya F; Tomita K; Hoffman RM
    J Cell Biochem; 2009 Oct; 108(2):362-7. PubMed ID: 19623575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for primary and metastatic pancreatic cancer with intraperitoneal retroviral vector bearing the wild-type p53 gene.
    Hwang RF; Gordon EM; Anderson WF; Parekh D
    Surgery; 1998 Aug; 124(2):143-50; discussion 150-1. PubMed ID: 9706132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells.
    Zhou P; Jiang W; Zhang YJ; Kahn SM; Schieren I; Santella RM; Weinstein IB
    Oncogene; 1995 Aug; 11(3):571-80. PubMed ID: 7630641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role of cyclin G in the process of apoptosis.
    Okamoto K; Prives C
    Oncogene; 1999 Aug; 18(32):4606-15. PubMed ID: 10467405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.